159 related articles for article (PubMed ID: 22579341)
1. Red blood cell membrane concentration of cis-palmitoleic and cis-vaccenic acids and risk of coronary heart disease.
Djoussé L; Matthan NR; Lichtenstein AH; Gaziano JM
Am J Cardiol; 2012 Aug; 110(4):539-44. PubMed ID: 22579341
[TBL] [Abstract][Full Text] [Related]
2. Plasma cis-vaccenic acid and risk of heart failure with antecedent coronary heart disease in male physicians.
Djoussé L; Matsumoto C; Hanson NQ; Weir NL; Tsai MY; Gaziano JM
Clin Nutr; 2014 Jun; 33(3):478-82. PubMed ID: 23880347
[TBL] [Abstract][Full Text] [Related]
3. Plasma phospholipid concentration of cis-palmitoleic acid and risk of heart failure.
Djoussé L; Weir NL; Hanson NQ; Tsai MY; Gaziano JM
Circ Heart Fail; 2012 Nov; 5(6):703-9. PubMed ID: 23065037
[TBL] [Abstract][Full Text] [Related]
4. Red blood cell MUFAs and risk of coronary artery disease in the Physicians' Health Study.
Matsumoto C; Matthan NR; Lichtenstein AH; Gaziano JM; Djoussé L
Am J Clin Nutr; 2013 Sep; 98(3):749-54. PubMed ID: 23824727
[TBL] [Abstract][Full Text] [Related]
5. Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study.
Wu JH; Lemaitre RN; Imamura F; King IB; Song X; Spiegelman D; Siscovick DS; Mozaffarian D
Am J Clin Nutr; 2011 Aug; 94(2):431-8. PubMed ID: 21697077
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of n-3 fatty acids and risk of coronary heart disease among Japanese: The Japan Public Health Center-based (JPHC) study.
Hamazaki K; Iso H; Eshak ES; Ikehara S; Ikeda A; Iwasaki M; Hamazaki T; Tsugane S;
Atherosclerosis; 2018 May; 272():226-232. PubMed ID: 29277442
[TBL] [Abstract][Full Text] [Related]
7. Circulating omega-7 fatty acids are differentially related to metabolic dysfunction and incident type II diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA).
Weir NL; Steffen BT; Guan W; Johnson LM; Djousse L; Mukamal KJ; Tsai MY
Diabetes Metab; 2020 Sep; 46(4):319-325. PubMed ID: 31706030
[TBL] [Abstract][Full Text] [Related]
8. Endogenous red blood cell membrane fatty acids and sudden cardiac arrest.
Lemaitre RN; King IB; Sotoodehnia N; Knopp RH; Mozaffarian D; McKnight B; Rea TD; Rice K; Friedlander Y; Lumley TS; Raghunathan TE; Copass MK; Siscovick DS
Metabolism; 2010 Jul; 59(7):1029-34. PubMed ID: 20045147
[TBL] [Abstract][Full Text] [Related]
9. Serum fatty acids and the risk of coronary heart disease.
Simon JA; Hodgkins ML; Browner WS; Neuhaus JM; Bernert JT; Hulley SB
Am J Epidemiol; 1995 Sep; 142(5):469-76. PubMed ID: 7677125
[TBL] [Abstract][Full Text] [Related]
10. A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non-Hodgkin lymphoma.
Chiu YH; Bertrand KA; Zhang S; Laden F; Epstein MM; Rosner BA; Chiuve S; Campos H; Giovannucci EL; Chavarro JE; Birmann BM
Int J Cancer; 2018 Oct; 143(8):1914-1922. PubMed ID: 29756258
[TBL] [Abstract][Full Text] [Related]
11. Relation between plasma phospholipid oleic acid and risk of heart failure.
Morin SJ; Gaziano JM; Djoussé L
Eur J Nutr; 2018 Dec; 57(8):2937-2942. PubMed ID: 29094199
[TBL] [Abstract][Full Text] [Related]
12. Palmitoleic (16:1 cis-9) and cis-vaccenic (18:1 cis-11) acid alter lipogenesis in bovine adipocyte cultures.
Burns TA; Kadegowda AK; Duckett SK; Pratt SL; Jenkins TC
Lipids; 2012 Dec; 47(12):1143-53. PubMed ID: 23077002
[TBL] [Abstract][Full Text] [Related]
13. Red blood cell folate concentrations and coronary heart disease prevalence: A cross-sectional study based on 1999-2012 National Health and Nutrition Examination Survey.
Peng Y; Wang Z
Nutr Metab Cardiovasc Dis; 2017 Nov; 27(11):1015-1020. PubMed ID: 28844321
[TBL] [Abstract][Full Text] [Related]
14. Plasma phospholipid trans fatty acids and risk of heart failure.
Tokede OA; Petrone AB; Hanson NQ; Tsai MY; Weir NA; Glynn RJ; Gaziano JM; Djoussé L
Am J Clin Nutr; 2013 Apr; 97(4):698-705. PubMed ID: 23446892
[TBL] [Abstract][Full Text] [Related]
15. Association Between Fatty Acids of Blood Cell Membranes and Incidence of Coronary Heart Disease.
Papandreou C; Sala-Vila A; Galié S; Muralidharan J; Estruch R; Fitó M; Razquin C; Corella D; Ros E; Timiraos J; Lapetra J; Serra-Majem L; Carlos S; Castañer O; Asensio EM; Salas-Salvadó J; Bulló M
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):819-825. PubMed ID: 30727755
[TBL] [Abstract][Full Text] [Related]
16. Baker's Yeast Deficient in Storage Lipid Synthesis Uses cis-Vaccenic Acid to Reduce Unsaturated Fatty Acid Toxicity.
Sec P; Garaiova M; Gajdos P; Certik M; Griac P; Hapala I; Holic R
Lipids; 2015 Jul; 50(7):621-30. PubMed ID: 25908426
[TBL] [Abstract][Full Text] [Related]
17. Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study.
Chajès V; Thiébaut AC; Rotival M; Gauthier E; Maillard V; Boutron-Ruault MC; Joulin V; Lenoir GM; Clavel-Chapelon F
Am J Epidemiol; 2008 Jun; 167(11):1312-20. PubMed ID: 18390841
[TBL] [Abstract][Full Text] [Related]
18. Circulating Very-Long-Chain Saturated Fatty Acids and Incident Coronary Heart Disease in US Men and Women.
Malik VS; Chiuve SE; Campos H; Rimm EB; Mozaffarian D; Hu FB; Sun Q
Circulation; 2015 Jul; 132(4):260-8. PubMed ID: 26048094
[TBL] [Abstract][Full Text] [Related]
19. Circulating Fatty Acids and Risk of Coronary Heart Disease and Stroke: Individual Participant Data Meta-Analysis in Up to 16 126 Participants.
Borges MC; Schmidt AF; Jefferis B; Wannamethee SG; Lawlor DA; Kivimaki M; Kumari M; Gaunt TR; Ben-Shlomo Y; Tillin T; Menon U; Providencia R; Dale C; Gentry-Maharaj A; Hughes A; Chaturvedi N; Casas JP; Hingorani AD;
J Am Heart Assoc; 2020 Mar; 9(5):e013131. PubMed ID: 32114887
[TBL] [Abstract][Full Text] [Related]
20. Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study.
Khaw KT; Friesen MD; Riboli E; Luben R; Wareham N
PLoS Med; 2012; 9(7):e1001255. PubMed ID: 22802735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
